Maren Goetz

Maren Goetz

Auto-generated profile, based on publicly available information

Maren Goetz

Department of Obstetrics and Gynecology Heidelberg University Heidelberg Germany

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 May 2017 in JMIR mHealth and uHealth
Verified
Journal Article
Open access
MGMaren Goetz
Maren Goetz
MMMitho Müller
Mitho Müller
LMLina Maria Matthies
Lina Maria Matthies
JHJenny Hansen
Jenny Hansen
ADAnne Doster
Anne Doster
SWStephanie Wallwiener
Stephanie Wallwiener
Mobile and tablet apps, ubiquitous and pervasive computing, wearable computing and domotics for health.

11 August 2020 in Journal of Medical Internet Research
Verified
Journal Article
Open access
MGMaren Goetz
Maren Goetz
CSClaudia Schiele
Claudia Schiele
MMMitho Müller
Mitho Müller
LMLina M Matthies
Lina M Matthies
TDThomas M Deutsch
Thomas M Deutsch
SWStephanie Wallwiener
Stephanie Wallwiener
Background: Peripartum depression and anxiety disorders are highly prevalent and are correlated with adverse maternal and neonatal outcomes. Antenatal care in Germany does not yet include structured screening and effective low-threshold treatment options for women facing peripartum depression and anxiety disorders. Mindfulness-based interventions (MBIs) are increasingly becoming a focus of interest for the management of such patients. Studies have shown a decrease in pregnancy-related stress and anxiety in expectant mothers following mindfulness programs. Objective: The aim of this study was to explore the clinical effectiveness of a 1-week electronic course of mindfulness on prenatal depression and anxiety in hospitalized, high-risk pregnant women. We hypothesized that participating in a 1-week electronic MBI (eMBI) could alleviate symptoms of depression and anxiety during the hospital stay. Methods: A prospective pilot study with an explorative study design was conducted from January to May 2019 in a sample of 68 women hospitalized due to high-risk pregnancies. After enrolling into the study, the participants were given access to an eMBI app on how to deal with stress, anxiety, and symptoms of depression. Psychometric parameters were assessed via electronic questionnaires comprising the Edinburgh Postnatal Depression Scale (EPDS), State-Trait Anxiety Inventory (STAI-S), and abridged version of the Pregnancy-Related Anxiety Questionnaire (PRAQ-R). Results: We observed a high prevalence of peripartum depression and anxiety among hospitalized high-risk pregnant women: 39% (26/67) of the study participants in the first assessment and 41% (16/39) of the participants in the second assessment achieved EPDS scores above the cutoff value for minor/major depression. The number of participants with anxiety levels above the cutoff value (66% [45/68] of the participants in the first assessment and 67% [26/39] of the participants in the second assessment) was significantly more than that of the participants with anxiety levels below the cutoff value, as measured with the STAI-S. After completing the 1-week electronic course on mindfulness, the participants showed a significant reduction in the mean state anxiety levels (P<.03). Regarding pregnancy-related anxiety, participants who completed more than 50% of the 1-week course showed lower scores in PRAQ-R in the second assessment (P<.05). No significant changes in the EPDS scores were found after completing the intervention. Conclusions: Peripartum anxiety and depression represent a relevant health issue in hospitalized pregnant patients. Short-term eMBIs could have the potential to reduce anxiety levels and pregnancy-related anxiety. However, we observed that compliance to eMBI seems to be related to lower symptoms of pregnancy-related stress among high-risk patients. eMBIs represent accessible mental health resources at reduced costs and can be adapted for hospitalized patients during pregnancy.

10 December 2021 in JMIR Mental Health
Verified
Journal Article
Open access
KHKathrin Hassdenteufel
Kathrin Hassdenteufel
KLKatrin Lingenfelder
Katrin Lingenfelder
CSCornelia E Schwarze
Cornelia E Schwarze
MFManuel Feisst
Manuel Feisst
KBKatharina Brusniak
Katharina Brusniak
SWStephanie Wallwiener
Stephanie Wallwiener
Background: Postpartum depression (PPD) is a severe mental disorder that often results in poor maternal-infant attachment and negatively impacts infant development. Universal screening has recently been recommended to identify women at risk, but the optimal screening time during pregnancy has not been defined so far. Thus, web-based technologies with widespread use among women of childbearing age create new opportunities to detect pregnancies with a high risk for adverse mental health outcomes at an early stage. Objective: The aim of this study was to stratify the risk for PPD and to determine the optimal screening time during pregnancy by using a web-based screening tool collecting electronic patient-reported outcomes (ePROs) as the basis for a screening algorithm. Methods: In total, 214 women were repeatedly tested for depressive symptoms 5 times during and 3 times after pregnancy by using the Edinburgh Postnatal Depression Scale (EPDS), accessible on a web-based pregnancy platform, developed by the authors of this study. For each prenatal assessment, the area under the curve (AUC), sensitivity, specificity, and predictive values for PPD were calculated. Multivariate logistic regression analyses were applied to identify further potential predictors, such as age, education, parity, relationship quality, and anxiety, to increase predictive accuracy. Results: Digitally collected data from 214 pregnant women were analyzed. The predictive accuracy of depressive symptoms 3 and 6 months postpartum was reasonable to good regarding the screening in the second (AUC=0.85) and third (AUC=0.75) trimester. The multivariate logistic regression analyses resulted in an excellent AUC of 0.93 at 3 months and a good AUC of 0.87 at 6 months postpartum. Conclusions: The best predictive accuracy for PPD has been shown for screening between the 24th and the 28th gestational week (GW) and seems to be beneficial for identifying women at risk. In combination with the aforementioned predictive factors, the discriminatory power improved, particularly at 3 months postpartum. Screening for depression during pregnancy, combined with the women’s personal risk profile, can be used as a starting point for developing a digital screening algorithm. Thereby, web-based assessment tools constitute feasible, efficient, and cost-effective approaches. Thus, they seem to be beneficial in detecting high-risk pregnancies in order to improve maternal and infant birth outcomes in the long term.

23 December 2019 in JMIR Preprints
Verified
Preprint
Open access
MGMaren Goetz
Maren Goetz
CSClaudia Schiele
Claudia Schiele
MMMitho Müller
Mitho Müller
LMLina M Matthies
Lina M Matthies
TDThomas M Deutsch
Thomas M Deutsch
SWStephanie Wallwiener
Stephanie Wallwiener
BACKGROUND Peripartum depression and anxiety disorders are highly prevalent and are correlated with adverse maternal and neonatal outcomes. Antenatal care in Germany does not yet include structured screening and effective low-threshold treatment options for women facing peripartum depression and anxiety disorders. Mindfulness-based interventions (MBIs) are increasingly becoming a focus of interest for the management of such patients. Studies have shown a decrease in pregnancy-related stress and anxiety in expectant mothers following mindfulness programs. OBJECTIVE The aim of this study was to explore the clinical effectiveness of a 1-week electronic course of mindfulness on prenatal depression and anxiety in hospitalized, high-risk pregnant women. We hypothesized that participating in a 1-week electronic MBI (eMBI) could alleviate symptoms of depression and anxiety during the hospital stay. METHODS A prospective pilot study with an explorative study design was conducted from January to May 2019 in a sample of 68 women hospitalized due to high-risk pregnancies. After enrolling into the study, the participants were given access to an eMBI app on how to deal with stress, anxiety, and symptoms of depression. Psychometric parameters were assessed via electronic questionnaires comprising the Edinburgh Postnatal Depression Scale (EPDS), State-Trait Anxiety Inventory (STAI-S), and abridged version of the Pregnancy-Related Anxiety Questionnaire (PRAQ-R). RESULTS We observed a high prevalence of peripartum depression and anxiety among hospitalized high-risk pregnant women: 39% (26/67) of the study participants in the first assessment and 41% (16/39) of the participants in the second assessment achieved EPDS scores above the cutoff value for minor/major depression. The number of participants with anxiety levels above the cutoff value (66% [45/68] of the participants in the first assessment and 67% [26/39] of the participants in the second assessment) was significantly more than that of the participants with anxiety levels below the cutoff value, as measured with the STAI-S. After completing the 1-week electronic course on mindfulness, the participants showed a significant reduction in the mean state anxiety levels (P<.03). Regarding pregnancy-related anxiety, participants who completed more than 50% of the 1-week course showed lower scores in PRAQ-R in the second assessment (P<.05). No significant changes in the EPDS scores were found after completing the intervention. CONCLUSIONS Peripartum anxiety and depression represent a relevant health issue in hospitalized pregnant patients. Short-term eMBIs could have the potential to reduce anxiety levels and pregnancy-related anxiety. However, we observed that compliance to eMBI seems to be related to lower symptoms of pregnancy-related stress among high-risk patients. eMBIs represent accessible mental health resources at reduced costs and can be adapted for hospitalized patients during pregnancy.

8 October 2026 in Journal of Medical Internet Research
Verified
Journal Article
Open access
MFMichelle Foerstel
Michelle Foerstel
KKKristina Killinger
Kristina Killinger
MMMitho Mueller
Mitho Mueller
VEVerena Engel
Verena Engel
KSKatrin Schlobohm
Katrin Schlobohm
SWStephanie Wallwiener
Stephanie Wallwiener
Background: The journey to parenthood involves significant physical, emotional, and psychosocial changes. Mental health challenges impact both maternal and fetal health, potentially leading to obstetric complications and developmental risks for children. Access to needed perinatal support is often limited due to individual and structural barriers. Digital health solutions can offer opportunities to provide low-threshold, personalized, and scalable support. We developed a digital navigator offering personalized guidance and connecting users to relevant support services with interactive follow-ups to self-assess their well-being. However, evidence regarding the feasibility of digital solutions in high-risk patients is limited. Objective: This study aimed to assess the feasibility and usability of a digital perinatal navigator app designed to provide personalized support and connect individuals with high-risk pregnancies to relevant health and social services. Methods: Conducted at University Women’s Hospital Heidelberg, the study used convenience sampling for a 2-week app test phase. A convergent mixed methods design integrated qualitative interviews (n=30) with psychometric surveys (n=35). Analyses included thematic analysis of interviews, descriptive statistics, 2-tailed paired t tests, and Pearson correlations. Results were triangulated at the end to better understand barriers to use. Results: Participants (median age 33 years; median gestational age 30 weeks) reported moderate to high rates of stress, anxiety, and depressive symptoms. Usability ratings were excellent (median System Usability Scale [SUS] score 80, IQR 17.5; median mHealth App Usability Questionnaire [MAUQ] score 111, IQR 28). Knowledge of health service providers increased significantly (mean +1.2 points; P<.01), with modest improvements in use. Qualitative analysis revealed key success factors such as intuitive structure, trustworthy medical content, and personalized information. Technical disruptions, navigation challenges, limited personalization, and incomplete regional integration of health care services were reported as barriers. Conclusions: The results indicate high feasibility and usability for our digital navigator in this high-risk population. The identified barriers are to be considered in the further development of the app and other perinatal digital care programs.

20 December 2020 in JMIR Preprints
Verified
Preprint
Open access
KHKathrin Hassdenteufel
Kathrin Hassdenteufel
KLKatrin Lingenfelder
Katrin Lingenfelder
CSCornelia E Schwarze
Cornelia E Schwarze
MFManuel Feisst
Manuel Feisst
KBKatharina Brusniak
Katharina Brusniak
SWStephanie Wallwiener
Stephanie Wallwiener
BACKGROUND Postpartum depression (PPD) is a severe mental disorder that often results in poor maternal-infant attachment and negatively impacts infant development. Universal screening has recently been recommended to identify women at risk, but the optimal screening time during pregnancy has not been defined so far. Thus, web-based technologies with widespread use among women of childbearing age create new opportunities to detect pregnancies with a high risk for adverse mental health outcomes at an early stage. OBJECTIVE The aim of this study was to stratify the risk for PPD and to determine the optimal screening time during pregnancy by using a web-based screening tool collecting electronic patient-reported outcomes (ePROs) as the basis for a screening algorithm. METHODS In total, 214 women were repeatedly tested for depressive symptoms 5 times during and 3 times after pregnancy by using the Edinburgh Postnatal Depression Scale (EPDS), accessible on a web-based pregnancy platform, developed by the authors of this study. For each prenatal assessment, the area under the curve (AUC), sensitivity, specificity, and predictive values for PPD were calculated. Multivariate logistic regression analyses were applied to identify further potential predictors, such as age, education, parity, relationship quality, and anxiety, to increase predictive accuracy. RESULTS Digitally collected data from 214 pregnant women were analyzed. The predictive accuracy of depressive symptoms 3 and 6 months postpartum was reasonable to good regarding the screening in the second (AUC=0.85) and third (AUC=0.75) trimester. The multivariate logistic regression analyses resulted in an excellent AUC of 0.93 at 3 months and a good AUC of 0.87 at 6 months postpartum. CONCLUSIONS The best predictive accuracy for PPD has been shown for screening between the 24th and the 28th gestational week (GW) and seems to be beneficial for identifying women at risk. In combination with the aforementioned predictive factors, the discriminatory power improved, particularly at 3 months postpartum. Screening for depression during pregnancy, combined with the women’s personal risk profile, can be used as a starting point for developing a digital screening algorithm. Thereby, web-based assessment tools constitute feasible, efficient, and cost-effective approaches. Thus, they seem to be beneficial in detecting high-risk pregnancies in order to improve maternal and infant birth outcomes in the long term.